Related Experiment Video
Updated: Jun 22, 2026
05:47
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
Published on: May 13, 2015
Thymic carcinoma in myasthenia gravis developing years after thymectomy
Hans D Katzberg1, Robert G Miller, Jonathan Katz
1Department of Neurology, Stanford University, Stanford, California, USA. katzenberg@stanford.edu
Muscle & Nerve
|June 18, 2009
Summary
Two myasthenia gravis patients developed thymic carcinoma years after thymectomy. This highlights the potential for new paraneoplastic syndromes and raises questions about long-term patient monitoring after surgery.
Area of Science:
- Oncology
- Neurology
- Immunology
Background:
- Myasthenia gravis (MG) is an autoimmune neuromuscular disease often associated with thymic abnormalities.
- Thymectomy is a common treatment for MG, aiming to remove the source of autoimmune response.
- Paraneoplastic syndromes can occur with malignancies, but their development years after initial treatment is less understood.
Observation:
- Two patients who underwent thymectomy for MG later developed thymic carcinoma.
- Initial thymic pathology in these patients included normal tissue and an encapsulated benign thymoma.
Findings:
- These cases suggest that MG can present as a paraneoplastic syndrome even after thymectomy.
- Late-onset thymic carcinoma can occur years post-thymectomy, irrespective of initial thymic findings.
Implications:
- The findings challenge the assumption that thymectomy eliminates all thymic-related risks in MG patients.
- This necessitates re-evaluating long-term surveillance strategies for patients with a history of thymectomy for MG.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...